A Patient-Reported Outcomes Analysis Of Lanreotide In The Treatment Of NETs Patients With Carcinoid Syndrome: Evidence From The ELECT Trial

A Patient-Reported Outcomes Analysis Of Lanreotide In The Treatment Of NETs Patients With Carcinoid Syndrome: Evidence From The ELECT Trial

Koenraad Blot,1 Luc Duchateau,2 Benedicte Lescrauwaet,3 Nilani Liyanage,4 David Ray,5 Beloo Mirakhur,5 Aaron I Vinik6 1Alacrita Consulting Ltd, London, UK; 2Department of Comparative Physiology and Biometrics, Faculty of Veterinary Medicine, Ghent University, Ghent, Belgium; 3Xintera Bvba, Ghent, Be...

Full description

Bibliographic Details
Main Authors: Blot K, Duchateau L, Lescrauwaet B, Liyanage N, Ray D, Mirakhur B, Vinik AI
Format: Article
Language:English
Published: Dove Medical Press 2019-10-01
Series:Patient Related Outcome Measures
Subjects:
lanreotide
patient-reported outcomes
neuroendocrine tumors
nets
Online Access:https://www.dovepress.com/a-patient-reported-outcomes-analysis-of-lanreotide-in-the-treatment-of-peer-reviewed-article-PROM

Internet

https://www.dovepress.com/a-patient-reported-outcomes-analysis-of-lanreotide-in-the-treatment-of-peer-reviewed-article-PROM

Similar Items